Comparing the current results to its competitors, Lifeward Ltd reported Revenue increase in the 2 quarter 2026 by 15.71 % year on year. The sales growth was above Lifeward Ltd 's competitors' average revenue growth of 15.61 %, achieved in the same quarter.
Lifeward Ltd 's Comment on Competition and Industry Peers
The company operates in the medical exoskeleton market, competing with firms such as Ekso Bionics, Rex Bionics, Cyberdyne, FREE Bionics, and Wandercraft. These competitors offer products for institutional use and, increasingly, for personal use. The company also faces competition from alternative devices and therapies, including treadmill-based gait therapies provided by DIH (formerly Hocoma), Boost, Aretech, BTL, Reha Technology, and Bioness, a unit of Bioventus. The competitive environment may change as new technologies and products emerge from medical device and robotics companies, as well as academic and research institutions. Competitors may possess advantages in marketing, financial resources, and customer relationships that could affect the company's market position. Other competitors referenced in company filings include AlterG, ReStore, and ReWalk.
Overall company sales advanced by 15.71 % Lifeward Ltd outperformed its competitors in this segment and improved market share, to approx. 0.03 %. << More on LFWD Market Share.
*Market share is calculated based on total revenue.
April 15, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 Lifeward, a pioneering company at the forefront of medical technology, has announced the launch of the ReWalk 7 personal exoskeleton in the U.S. market. This state-of-the-art seventh-generation device is designed for individuals with spinal cord injuries, enabling greater mobility and independence. The launch represents a significant milestone in Lifeward s commitment to enhancing the quality of life for those affected by severe mobility impairments.The ReWalk 7 exoskeleton builds upon the success of its predecessors, leveraging advanced robotics and cutting-edge engineering to create a device that mimics natural walking patterns. Equipped with ...
Ss Innovations International Inc Share Performance
0.00%
This Quarter
Ss Innovations International Inc
Profile
Avra Medical Robotics Inc's business model revolves around developing and commercializing medical robotics and digital technologies for use in surgical procedures. They aim to enhance surgical precision, efficiency, and patient outcomes by providing advanced robotic systems to healthcare facilities.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Intuitive Surgical Incs business model focuses on delivering robotic surgical systems, particularly the da Vinci Surgical System, which facilitates minimally invasive surgeries. Revenue is generated through system sales, instruments, accessories, and services, including training and maintenance for healthcare providers.
Ekso Bionics Holdings Inc's business model centers around developing and manufacturing exoskeleton systems that enhance human mobility and strength. These advanced wearable technologies are designed to assist individuals with limited mobility due to various medical conditions or physical impairments.
Axon Enterprise Inc operates on a business model that focuses on providing law enforcement agencies with comprehensive solutions for digital evidence management and body-worn cameras. The company primarily generates revenue through the sale of its hardware products like body cameras and TASER devices. It also offers software and services for data storage, analysis, and management, aiming to create long-term partnerships with law enforcement agencies.
Sources:
Lifeward ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Lifeward ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
